Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by eSnowdenon Mar 04, 2014 5:57pm

274 Views

Post# 22280132

RE:RE:Company valuation is pathetic.

US-based Elite Pharma (ELTP) has similar financials to Medicure, primarily into generics, and has nothing near the potential of a transdermal Aggrastat in their portfolio, yet has a market cap of over $400million...

If Medicure became US-based (of which they have offices in New Jersey), and promoted their company a bit more, you could easily see a valuation between $50-$100million on a US exchange.

Reasons for the current share price? By solely relying on Canadian investors--the real money is in the US. There is a cross-listed ticker (MCUJF)--of which I own shares. Yet, my brokerage no longer allows purchases of foreign stocks, only allows the sale of existing shares.

Bullboard Posts

This AI stock is disrupting the event tickets monopoly